Literatur

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis. A randomised trial.

In: Lancet 354, S. 635–639.

Weitere Veröffentlichungen:

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis

Weitere Informationen

Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants.

Weitere Informationen

Schutzwirkung von Escherichia coli Nissle 1917 gegen Influenza A

Weitere Informationen

Rembacken, B. J.; Snelling, A. M.; Hawkey, P. M.; Chalmers, D. M.; Axon, A. T. R. (1999): Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis. A randomised trial.